In July, India’s domestic pharma retail market experienced an 11% growth, driven by sales of anti-infectives and pain-relief medicines due to increased flu and viral infections. Augmentin emerged as the top-selling brand with Rs 72 crore in sales. Acute therapies, including pain and anti-infectives, grew by 11%, while chronic medications increased by 12%.
Related Posts
Honeywell automation to carry out airfield ground lighting project for Noida airport
Honeywell Automation India Limited will provide its Airfield Ground Lighting system for Noida International Airport, enhancing safety and operational efficiency with advanced visual guidance. The […]
Market capitalization of 8 of top-10 most valued companies soars Rs 1.21 lakh crore
Eight of the top-10 most valued companies saw a combined market valuation increase of Rs 1,21,270.83 crore last week, driven primarily by Reliance Industries. This […]
‘US Department of Justice has no business…’: Mark Mobius says US DOJ overstepped bounds on Adani case
Mark Mobius believes the US Justice Department’s indictment of Gautam Adani, was probably an overstepping of mandate. He anticipates a decrease in international corporate prosecutions […]